Free Trial

JPMorgan Chase & Co. Buys 79,901 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Aspen Aerogels logo with Construction background

JPMorgan Chase & Co. lifted its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 311.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 105,591 shares of the construction company's stock after acquiring an additional 79,901 shares during the period. JPMorgan Chase & Co. owned approximately 0.13% of Aspen Aerogels worth $1,254,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of ASPN. Morse Asset Management Inc acquired a new stake in Aspen Aerogels in the 3rd quarter worth $264,000. AlphaQuest LLC grew its position in Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock worth $135,000 after buying an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in Aspen Aerogels during the fourth quarter valued at about $164,000. Journey Strategic Wealth LLC acquired a new position in Aspen Aerogels in the 4th quarter valued at approximately $178,000. Finally, Ballentine Partners LLC grew its holdings in shares of Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after purchasing an additional 2,565 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

ASPN has been the subject of a number of recent research reports. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a research note on Tuesday, March 11th. B. Riley reduced their price objective on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. Barclays lowered their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. Canaccord Genuity Group dropped their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 14th. Finally, Roth Mkm decreased their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of "Moderate Buy" and an average price target of $19.11.

Check Out Our Latest Stock Report on ASPN

Aspen Aerogels Price Performance

Shares of ASPN stock traded up $0.09 during trading hours on Thursday, reaching $5.49. 150,821 shares of the company were exchanged, compared to its average volume of 1,925,110. Aspen Aerogels, Inc. has a fifty-two week low of $4.80 and a fifty-two week high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The stock's fifty day moving average is $6.38 and its two-hundred day moving average is $11.41. The company has a market cap of $450.35 million, a price-to-earnings ratio of 34.28 and a beta of 2.35.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Sell-side analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines